Clinical Trials Logo
  1. Home
  2. Painful Bladder Syndrome
  3. NCT02868775

A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome

Painful Bladder Syndrome Clinical Trial

Official title:
A Pilot Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome

Clinical Trial Summary

This is a prospective pilot study, with a recruitment goal of 60 patients. Patients who are female, above the age of 18, and with a diagnosis of IC/BPS based on clinical criteria and O'Leary Sant ICPI and ICSI scores undergoing cystoscopy, hydrodistention and bladder biopsy will be included. The bladder biopsies will be evaluated for TLR4 expression, and sent for histological assessment of mast cell count. Additionally, data will be collected at baseline, day of surgery, day 7, day 14 and day 28. Data will include validated questionnaires, lower urinary tract symptoms, and recorded pain medication use.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02868775
Study type Observational
Source Philadelphia Urosurgical Associates
Contact Kristene Whitmore, MD
Phone 2158638100
Email bladder1@aol.com
Status Recruiting
Phase N/A
Start date September 2016
Completion date October 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT04313972 - IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone Phase 4
Not yet recruiting NCT01410461 - Identifying Predictors of Treatment Success in Painful Bladder Syndrome N/A
Completed NCT01197261 - OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS) Phase 2
Completed NCT00150488 - URACYST® For the Treatment of GAG Deficient Interstitial Cystitis N/A
Completed NCT00672087 - Diagnostic Challenges in IC (and Male CPPS)
Completed NCT02232282 - Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial N/A
Completed NCT00775281 - Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. N/A
Completed NCT05223244 - Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC Phase 4
Completed NCT02600715 - Reduction of Bladder Injection Pain With Belladonna Opiate Suppository Phase 4
Completed NCT02457182 - Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome N/A
Withdrawn NCT03027076 - Microbiome of Urologic Chronic Pelvic Pain Syndrome N/A
Completed NCT00434343 - Physical Therapy Trial for Pelvic Pain N/A
Terminated NCT03143920 - Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder Early Phase 1
Completed NCT02411110 - A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome Phase 2
Completed NCT00903643 - Sensory Processing in Subjects With Painful Bladder Syndrome N/A
Completed NCT00194610 - Botox as a Treatment for Interstitial Cystitis in Women Phase 4
Terminated NCT04268810 - Prospective Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of PBS/Interstitial Cystitis Phase 4
Completed NCT01294878 - Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome Phase 3
Terminated NCT00451867 - A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . Phase 3
Not yet recruiting NCT06096597 - Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome Phase 3